CDCA3 and gastric cancer: Adams et al. suggested CDCA3 as a prognostic biomarker and potential therapeutic target in non-small–cell lung cancer [29], and Zhang et al. suggested CDCA3 as a potential prognostic marker in gastric cancer [30].